©2024 Stanford Medicine
Impact of C-arm CT in Decreased Renal Function Undergoing TACE for Tx of Hepato-Cellular Carcinoma
Not Recruiting
Trial ID: NCT01326390
Purpose
Impact on contrast dose or total volume of contrast required to effectively treat the
targeted tumor.
Official Title
Impact of C-arm CT in Patients With Decreased Renal Function Undergoing Transhepatic Arterial Chemoembolization (TACE) for the Treatment of Hepato-Cellular Carcinoma
Stanford Investigator(s)
Nishita Kothary, MD
Professor of Radiology (Interventional Radiology)
Gloria Hwang, MD
Clinical Professor, Radiology
Lawrence "Rusty" Hofmann, MD
Professor of Radiology (Interventional Radiology)
David Hovsepian, MD
Clinical Professor, Radiology
John D. Louie, MD
Clinical Professor, Radiology
Daniel Sze, MD, PhD
Professor of Radiology (Interventional Radiology)
WILLIAM T. KUO, MD, FSIR, FCCP, FSVM, FACR, FCIRSE
Professor of Radiology (Interventional Radiology)
Eligibility
Inclusion Criteria:
1. Patients must be affected by HCC
2. Patients must have diminished renal function (GFR<60 ml/min/1.73m^2)
3. Patients must be 18 years old or older
4. Patients must have received an abdominal CT, PET/CT scan or MRI, completed prior to
the TACE procedure.
5. Ability to understand and the willingness to sign a written informed consent document.
Exclusion Criteria:
1. Subjects under the age of 18
2. Patients currently on dialysis
3. Pregnant women
Intervention(s):
device: dTA/dBA C-arm fluoroscopy system with Dyna CT
procedure: DSA arteriogram- hepatic arteries
procedure: CO2 aortogram
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
ccto-office@stanford.edu
650-498-7061